Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Winblad

Showing results (481-490 of 538) with videos related to

Pageof 54
Sort By:
Brain Communications|October 20, 2022
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patientsBjørn Eivind Kirsebom, Grit Richter, Kaja Nordengen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 24, 2022
Clinical research in dementia: A perspective on implementing innovationMarina Boccardi, Ron Handels, Michael Gold, et al.
Brain Communications|May 17, 2024
Association of objective sleep duration with cognition and brain aging biomarkers in older adultsShi Tang, Rui Liu, Juan Ren, et al.
Journal of Cellular and Molecular Medicine|December 21, 2021
γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processingTobias A Weber, Johan Lundkvist, Johanna Wanngren, et al.
Journal of Proteome Research|April 4, 2014
mTor is a signaling hub in cell survival: a mass-spectrometry-based proteomics investigationZhi Tang, Ahmet Tarik Baykal, Hui Gao, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2013
Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related modelsLouise Hedskog, Catarina Moreira Pinho, Riccardo Filadi, et al.
Journal of Alzheimer'S Disease : JAD|May 11, 2016
Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's DiseaseWalid Tajeddinn, Torbjörn Persson, Javier Calvo-Garrido, et al.
The Lancet Regional Health. Europe|May 30, 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpointLinus Jönsson, Anders Wimo, Ron Handels, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical settingAnders Wimo, Ron Handels, Kaj Blennow, et al.
Frontiers in Neuroscience|April 18, 2022
Recent Advances in the Modeling of Alzheimer's DiseaseHiroki Sasaguri, Shoko Hashimoto, Naoto Watamura, et al.
Pageof 54

Showing results (481-490 of 538) with videos related to

Sort By:
Pageof 54
Brain Communications|October 20, 2022
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patientsBjørn Eivind Kirsebom, Grit Richter, Kaja Nordengen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 24, 2022
Clinical research in dementia: A perspective on implementing innovationMarina Boccardi, Ron Handels, Michael Gold, et al.
Brain Communications|May 17, 2024
Association of objective sleep duration with cognition and brain aging biomarkers in older adultsShi Tang, Rui Liu, Juan Ren, et al.
Journal of Cellular and Molecular Medicine|December 21, 2021
γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processingTobias A Weber, Johan Lundkvist, Johanna Wanngren, et al.
Journal of Proteome Research|April 4, 2014
mTor is a signaling hub in cell survival: a mass-spectrometry-based proteomics investigationZhi Tang, Ahmet Tarik Baykal, Hui Gao, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2013
Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related modelsLouise Hedskog, Catarina Moreira Pinho, Riccardo Filadi, et al.
Journal of Alzheimer'S Disease : JAD|May 11, 2016
Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's DiseaseWalid Tajeddinn, Torbjörn Persson, Javier Calvo-Garrido, et al.
The Lancet Regional Health. Europe|May 30, 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpointLinus Jönsson, Anders Wimo, Ron Handels, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical settingAnders Wimo, Ron Handels, Kaj Blennow, et al.
Frontiers in Neuroscience|April 18, 2022
Recent Advances in the Modeling of Alzheimer's DiseaseHiroki Sasaguri, Shoko Hashimoto, Naoto Watamura, et al.
Pageof 54